Brett Sandercock, Chief Financial Officer at RESMED INC (RMD), sold 7,288 shares at $244.59 ($1.8M) on 2025-05-22, disclosed to the SEC on 2025-05-27.
Scheduled sale ($1.8M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $244.59 | 3,644 | $891K | 50.0% |
| 2 | $244.59 | 3,644 | $891K | 50.0% |
| Total | $244.59 avg | 7,288 | $1.8M | 100% |
| Filing → |
| RMD | SELL | 2026-02-03 | $257K | — | Filing → |
| RMD | SELL | 2026-01-05 | $242K | — | Filing → |
| RMD | SELL | 2025-12-02 | $244K | — | Filing → |